9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration

      research-article
      1 , 2 , 3 , 4 , 12 , ,   5 , 9 , 10 , 6 , 7 , 6 , 7 , 8 , 5 , 9 , 10 , 11 , 1 , 2 , 3 , 4 , 6 , 7 , , on behalf of Synergy-COPD Consortia
      BMC Bioinformatics
      BioMed Central
      Statistical Methods for Omics Data Integration and Analysis 2015
      14-16 September 2015

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Deep mining of healthcare data has provided maps of comorbidity relationships between diseases. In parallel, integrative multi-omics investigations have generated high-resolution molecular maps of putative relevance for understanding disease initiation and progression. Yet, it is unclear how to advance an observation of comorbidity relations (one disease to others) to a molecular understanding of the driver processes and associated biomarkers.

          Results

          Since Chronic Obstructive Pulmonary disease (COPD) has emerged as a central hub in temporal comorbidity networks, we developed a systematic integrative data-driven framework to identify shared disease-associated genes and pathways, as a proxy for the underlying generative mechanisms inducing comorbidity. We integrated records from approximately 13 M patients from the Medicare database with disease-gene maps that we derived from several resources including a semantic-derived knowledge-base. Using rank-based statistics we not only recovered known comorbidities but also discovered a novel association between COPD and digestive diseases. Furthermore, our analysis provides the first set of COPD co-morbidity candidate biomarkers, including IL15, TNF and JUP, and characterizes their association to aging and life-style conditions, such as smoking and physical activity.

          Conclusions

          The developed framework provides novel insights in COPD and especially COPD co-morbidity associated mechanisms. The methodology could be used to discover and decipher the molecular underpinning of other comorbidity relationships and furthermore, allow the identification of candidate co-morbidity biomarkers.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s12859-016-1291-3) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Chronic obstructive pulmonary disease

            Summary Chronic obstructive pulmonary disease (COPD) is characterised by progressive airflow obstruction that is only partly reversible, inflammation in the airways, and systemic effects or comorbities. The main cause is smoking tobacco, but other factors have been identified. Several pathobiological processes interact on a complex background of genetic determinants, lung growth, and environmental stimuli. The disease is further aggravated by exacerbations, particularly in patients with severe disease, up to 78% of which are due to bacterial infections, viral infections, or both. Comorbidities include ischaemic heart disease, diabetes, and lung cancer. Bronchodilators constitute the mainstay of treatment: β2 agonists and long-acting anticholinergic agents are frequently used (the former often with inhaled corticosteroids). Besides improving symptoms, these treatments are also thought to lead to some degree of disease modification. Future research should be directed towards the development of agents that notably affect the course of disease.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Entrez Gene: gene-centered information at NCBI

              Entrez Gene (www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene) is NCBI's database for gene-specific information. It does not include all known or predicted genes; instead Entrez Gene focuses on the genomes that have been completely sequenced, that have an active research community to contribute gene-specific information, or that are scheduled for intense sequence analysis. The content of Entrez Gene represents the result of curation and automated integration of data from NCBI's Reference Sequence project (RefSeq), from collaborating model organism databases, and from many other databases available from NCBI. Records are assigned unique, stable and tracked integers as identifiers. The content (nomenclature, map location, gene products and their attributes, markers, phenotypes, and links to citations, sequences, variation details, maps, expression, homologs, protein domains and external databases) is updated as new information becomes available. Entrez Gene is a step forward from NCBI's LocusLink, with both a major increase in taxonomic scope and improved access through the many tools associated with NCBI Entrez.
                Bookmark

                Author and article information

                Contributors
                david.gomezcabrero@ki.se
                jroca@clinic.ub.es
                Conference
                BMC Bioinformatics
                BMC Bioinformatics
                BMC Bioinformatics
                BioMed Central (London )
                1471-2105
                22 November 2016
                22 November 2016
                2016
                : 17
                Issue : Suppl 15 Issue sponsor : Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The peer review process was overseen by the Supplement Editor in accordance with BioMed Central’s peer review guidelines for supplements. The Supplement Editor declares that they have no competing interests.
                : 23-35
                Affiliations
                [1 ]Department of Medicine, Karolinska Institutet, Unit of Computational Medicine, Stockholm, 171 77 Sweden
                [2 ]Karolinska Institutet, Center for Molecular Medicine, Stockholm, 171 77 Sweden
                [3 ]Department of Medicine, Unit of Clinical Epidemiology, Karolinska University Hospital, Solna, L8, 17176 Sweden
                [4 ]Science for Life Laboratory, Solna, 17121 Sweden
                [5 ]Center for Complex Networks Research and Department of Physics, Northeastern University, Boston, MA USA
                [6 ]Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain
                [7 ]Center for Biomedical Network Research in Respiratory Diseases (CIBERES), Madrid, Spain
                [8 ]Biomax Informatics AG, Planegg, Germany
                [9 ]Center for Cancer Systems Biology (CCSB) and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA USA
                [10 ]Center for Network Science, Central European University, Budapest, Hungary
                [11 ]Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA
                [12 ]Mucosal and Salivary Biology Division, King’s College London Dental Institute, London, UK
                Article
                1291
                10.1186/s12859-016-1291-3
                5133493
                28185567
                559921b1-6986-4f6c-86fe-7c90a844e6f8
                © The Author(s). 2016

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                Statistical Methods for Omics Data Integration and Analysis 2015
                Valencia, Spain
                14-16 September 2015
                History
                Categories
                Research
                Custom metadata
                © The Author(s) 2016

                Bioinformatics & Computational biology
                Bioinformatics & Computational biology

                Comments

                Comment on this article